Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Evidence, limitations and practical implications

Phytotherapy for anxiety disorders

    • RX
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • Psychiatry and psychotherapy
    • Studies
  • 8 minute read

Anxiety disorders are among the most common mental illnesses – and many sufferers want “natural” treatment options in addition to or as an alternative to conventional psychotropic drugs. For some herbal active ingredients – in particular standardized lavender oil, kava (Piper methysticum), ashwagandha (Withania somnifera), passion flower (Passiflora incarnata) and chamomile (Matricaria chamomilla) – a clinical database of randomized studies, systematic reviews and meta-analyses is now available. This shows that there are demonstrable anxiolytic effects, albeit with varying effect strengths, quality levels and safety profiles. The article summarizes the current evidence and outlines the clinical situations in which phytotherapeutic options can be usefully integrated – without replacing guideline-based therapies.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten
Already a member? Log in here
Autoren
  • Tanja Schliebe
Publikation
  • PHYTOTHERAPIE PRAXIS
Previous Article
  • Case report: Hiccups after ketoacidosis

Nebulized lidocaine brings relief

  • RX
  • Cardiology
  • Cases
  • Education
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Neurology
  • ORL
  • Pneumology
  • Studies
View Post
Next Article
  • Chronic inflammation as a driver of ageing

Immunosenescence and inflammaging

  • RX
  • Education
  • General Internal Medicine
  • Genetics
  • Geriatrics
  • Oncology
  • Prevention and health care
  • Studies
View Post
You May Also Like
View Post
  • 6 min
  • Advanced Thyroid Cancer

Molecular Mechanisms and New Therapeutic Approaches

    • RX
    • Education
    • Endocrinology and Diabetology
    • Oncology
View Post
  • 4 min
  • Epidermolysis bullosa

Promoting Wound Healing with Gene Therapies and Birch Bark Extract

    • RX
    • Dermatology and venereology
    • Education
    • Genetics
    • Pediatrics
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 18 min
  • From Risk Identification to Anti-Inflammatory Intervention

Inflammation as a Treatment Goal in Its Own Right

    • RX
    • Angiology
    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Studies
View Post
  • 3 min
  • Psoriasis Research: What's in the Pipeline?

Highly selective oral TYK inhibitors in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • Studies
View Post
  • 11 min
  • Cardiometabolism

Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • Studies
View Post
  • 7 min
  • Pediatric Retinoblastoma

The Tumor Microenvironment and Modern Eye-Sparing Therapies

    • RX
    • Education
    • Oncology
    • Ophthalmology
    • Pediatrics
View Post
  • 3 min
  • Adherence and management in asthma and COPD

Better to listen to the pharmacist

    • RX
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Pneumology
    • Studies
View Post
  • 14 min
  • Focus Update 2026

Echocardiography in Cardio-Oncology

    • RX
    • Cardiology
    • Education
    • Oncology
    • Radiology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.